Related Experiment Video
Updated: Apr 21, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Myelodysplasia in children: report of 2 cases
M C Savithri1, K P Kavitha2, Vanesa John2
1Department of Pathology, Amala Institute of Medical Sciences, Amalanagar, Thrissur, 680555, Kerala India ; G2, Sri Sai Apartments, Kunnath Mana Lane, Thrissur, 680001 Kerala India.
Abstract:
Myelodysplasia in children is rare. We report two cases presenting with pancytopaenia and macrocytosis with additional features suggestive of Fanconi anemia which is an autosomal recessive disorder in which there is progressive bone marrow failure and increased predisposition to malignancies especially AML. Hypersensitivity of FA cells to the chromosome-breaking effect of cross-linking agents provides a reliable cellular marker for the diagnosis of this disorder.
Insights
This study presents two rare pediatric myelodysplasia cases with pancytopenia and macrocytosis, suggesting Fanconi anemia (FA). FA is a genetic disorder causing bone marrow failure and cancer risk, diagnosed by cell hypersensitivity.
Area of Science:
- Pediatric Hematology
- Oncogenesis
- Genetic Disorders
Background:
- Myelodysplasia in children is uncommon.
- Fanconi anemia (FA) is an autosomal recessive disorder.
- FA leads to progressive bone marrow failure and malignancy risk, particularly acute myeloid leukemia (AML).
Observation:
- Two pediatric cases presented with pancytopenia and macrocytosis.
- Clinical features suggested Fanconi anemia.
Findings:
- FA cells exhibit hypersensitivity to chromosome-breaking agents.
- This hypersensitivity serves as a diagnostic marker for FA.
Implications:
- Early diagnosis of FA is crucial for managing bone marrow failure.
- Understanding FA's genetic basis aids in predicting malignancy risk.
- Cellular assays for FA can improve diagnostic accuracy in pediatric myelodysplasia.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Differentiation of Common Myeloid Progenitor Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

